Autism and Attachment. An Explorative Study of Attachment Styles in Autistic Adults. (ASDA)

April 19, 2024 updated by: Stephanie Bohnen, Parnassia Groep

Autism Spectrum Disorder and Attachment. An Explorative Study of Attachment Styles in Adults With Autism Spectrum Disorder

The present study examines the relationship between attachment and autism spectrum disorder (ASD) in adults.

Study Overview

Status

Recruiting

Conditions

Detailed Description

Rationale: Previous research on autism spectrum disorder (ASD) and attachment has improved understanding of the aetiology and development of the disorder. Research on adults with ASD, however is scarce. The study is focussed on attachment in adults with ASD. Objective: The aim of the current study is to explore attachment styles of adults with ASD and examining the relationship between attachment and ASD.

The study requires 60 participants.

Study Type

Observational

Enrollment (Estimated)

60

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Netherlands
    • Zuid-Holland
      • Rotterdam, Zuid-Holland, Netherlands, 3083 AK

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Adults (>18 years) with ASD, and without intellectual disability. Participants will be recruited from SARR Autism Rotterdam and Antes, both part of Parnassia Group in the Netherlands. SARR Autism Rotterdam is specialized in psychodiagnostic assessments and interventions for children, adolescents, and adults with ASD. Antes and Parnassia Group are multisite mental health institutes specialized in psychodiagnostic assessments and interventions for adults with a broad range of psychiatric disorders, including ASD.

Description

Inclusion Criteria:

  • Inclusion criteria are:

    • a primary clinical diagnosis of DSM-5 ASD (APA, 2013)
    • age 18 - 65 years
    • no intellectual disability (IQ > 80)

Exclusion Criteria:

  • acute psychosis
  • acute suicidality
  • psychotic disorder
  • intellectual disability (IQ < 80)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The Social Responsiveness Scale - Adult version (SRS-A)
Time Frame: 15 minutes
The SRS-A is a screening tool for identifying possible ASD characteristics in adults suspicious for ASD, is 64-item self-report questionnaire measuring various dimensions of interpersonal behavior, communication, and rigid, repetitive behaviour and interests, characteristic for adults with ASD. Each item is rated on a 1-4 point scale.
15 minutes
The Attachment Styles Questionnaire (ASQ)
Time Frame: 15 minutes
The ASQ is a questionnaire consisting of 24 items and assesses four attachment styles (secure, preoccupied, fearful, and dismissing). The 5-point rating scale ranges from 1 (strongly disagree) to 5 (strongly agree).
15 minutes
Experiences in Close Relationships - Revised questionnaire (ECR-r)
Time Frame: 15 minutes
The ECR-r measures adult attachment within romantic relationships in past and present in 36 items, consisting of two subscales of 18 items each (attachment anxiety and attachment avoidance). Each item is rated from 'strongly disagree' (1) to 'strongly agree' (7).
15 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Parnassia Groep

Investigators

  • Principal Investigator: Richard Vuijk, Dr., Parnassia Groep Antes

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2024

Primary Completion (Estimated)

April 1, 2025

Study Completion (Estimated)

April 1, 2025

Study Registration Dates

First Submitted

April 16, 2024

First Submitted That Met QC Criteria

April 16, 2024

First Posted (Actual)

April 19, 2024

Study Record Updates

Last Update Posted (Actual)

April 23, 2024

Last Update Submitted That Met QC Criteria

April 19, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2023.17
  • 2023.0871 (Other Identifier: METC Amsterdam UMC)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Autism Spectrum Disorder

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Saint Lucia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe